We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.1%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$946M
AUM Growth
+$84.3M
(+9.8%)
Cap. Flow
+$58.3M
Cap. Flow
% of AUM
6.17%
Top 10 Holdings %
Top 10 Hldgs %
5.74%
Holding
1,852
New
716
Increased
240
Reduced
255
Closed
635
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$5.94M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.81M |
| 3 |
Xcel Energy
XEL
|
+$5.01M |
| 4 |
General Mills
GIS
|
+$4.97M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$7.75M |
| 2 |
United Parcel Service
UPS
|
+$4.82M |
| 3 |
Yum! Brands
YUM
|
+$4.38M |
| 4 |
ConocoPhillips
COP
|
+$3.98M |
| 5 |
DuPont de Nemours
DD
|
+$3.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.73% |
| 2 | Consumer Discretionary | 14.9% |
| 3 | Industrials | 14.17% |
| 4 | Technology | 11.61% |
| 5 | Healthcare | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
VistaGen Therapeutics
VTGN
$10.4M
| $89.2K | 0.01% |
+47,696
| New | +$167K |
|
1127
Instil Bio
TIL
$48.9M
| $89K | 0.01% |
+8,074
| New | +$98.7K |
|
1128
GeneDx Holdings
WGS
$3.13B
| $88.4K | 0.01% |
+14,839
| New | +$117K |
|
1129
Momentus
MNTS
$95.3M
| $87.8K | 0.01% |
+22
| New | +$104K |
|
|
PLM
1130
DELISTED
PolyMet Mining Corp.
PLM
| $87.8K | 0.01% |
+111,179
| New | +$167K |
|
|
INN
1131
Summit Hotel Properties
INN
$617M
| $86.6K | 0.01% |
13,304
-4,101
| -24% | -$27.1K |
|
|
PRDS
1132
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $85.9K | 0.01% |
+47,469
| New | +$86.8K |
|
1133
Hope Bancorp
HOPE
$1.78B
| $85.1K | 0.01% |
10,103
-17,118
| -63% | -$149K |
|
1134
Sportsman's Warehouse
SPWH
$46.6M
| $83K | 0.01% |
14,562
-17,060
| -54% | -$103K |
|
1135
Hyliion Holdings
HYLN
$729M
| $82.8K | 0.01% |
+49,576
| New | +$83.5K |
|
1136
Xos
XOS
$37M
| $80.8K | 0.01% |
+12,376
| New | +$167K |
|
1137
ALX Oncology
ALXO
$241M
| $79.7K | 0.01% |
+10,615
| New | +$69.5K |
|
1138
Gran Tierra Energy
GTE
$362M
| $79.3K | 0.01% |
+16,152
| New | +$107K |
|
1139
Gossamer Bio
GOSS
$73M
| $79.3K | 0.01% |
826
-1,421
| -63% | -$142K |
|
1140
Celularity
CELU
$36.8M
| $78.9K | 0.01% |
14,815
+10,661
| +257% | +$68.3K |
|
1141
Playboy Inc
PLBY
$128M
| $78.7K | 0.01% |
+46,865
| New | +$79.2K |
|
1142
Groupon
GRPN
$765M
| $77.6K | 0.01% |
+13,123
| New | +$58.1K |
|
|
GPMT
1143
Granite Point Mortgage Trust
GPMT
$43.9M
| $77.4K | 0.01% |
+14,604
| New | +$69.3K |
|
|
RAD
1144
DELISTED
Rite Aid Corporation
RAD
| $77.3K | 0.01% |
+51,200
| New | +$103K |
|
1145
Praxis Precision Medicines
PRAX
$8.67B
| $77.3K | 0.01% |
+4,478
| New | +$68.6K |
|
1146
Heron Therapeutics
HRTX
$59.9M
| $76.9K | 0.01% |
+66,326
| New | +$118K |
|
1147
Ocugen
OCGN
$349M
| $76.8K | 0.01% |
141,491
-80,300
| -36% | -$51.5K |
|
|
STLN
1148
Starling Oncology
STLN
$676M
| $76.4K | 0.01% |
+138,899
| New | +$73.5K |
|
|
SILV
1149
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $76.3K | 0.01% |
+13,019
| New | +$85.5K |
|
1150
ICL Group
ICL
$7.14B
| $76K | 0.01% |
13,871
-10,474
| -43% | -$63.3K |
|
Similar funds
BGDI
WAM
TSC
MS
GIBU
YCM
ONB
VDI
Y-Intercept (HK)'s Q2 2023 Portfolio in Review
As of Q2 2023, Y-Intercept (HK) held 1,852 positions worth $946M, up 9.8% from $861M the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Y-Intercept (HK) deployed $58.3M of net new capital in Q2 2023, opening 716 new positions and adding to 240 existing holdings. Its largest new stake was Union Pacific: 29,892 shares worth $6.12M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was ConocoPhillips, an estimated $3.98M trimmed.
- Y-Intercept (HK)'s largest Q2 2023 buy was Union Pacific: 29,892 shares worth $6.12M.
- Y-Intercept (HK) added most to Blackstone in Q2 2023, an estimated $4.36M increase.
- Y-Intercept (HK)'s biggest Q2 2023 reduction was ConocoPhillips, cutting an estimated $3.98M.
- Y-Intercept (HK) fully exited Cigna in Q2 2023, selling an estimated $7.75M.
- Y-Intercept (HK)'s ten largest holdings make up 5.7% of its $946M portfolio in Q2 2023.
- Y-Intercept (HK) opened 716 new positions and closed 635 in Q2 2023.
- Y-Intercept (HK)'s portfolio value rose 9.8% quarter-over-quarter to $946M.
Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.